Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis.

about

Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries.

P2860

Q33891821-0E08C9CA-A7A2-4829-BE77-5FD5744735CC Q54210245-D31BB396-DD27-4EA5-8378-EC5226EA630A

P2860

Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis.

Item

http://www.wikidata.org/entity/Q36237280

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Immunogenicity and safety of h ...... ix countries: a meta-analysis.

@ast

Immunogenicity and safety of h ...... ix countries: a meta-analysis.

@en

type

Item

label

Immunogenicity and safety of h ...... ix countries: a meta-analysis.

@ast

Immunogenicity and safety of h ...... ix countries: a meta-analysis.

@en

prefLabel

Immunogenicity and safety of h ...... ix countries: a meta-analysis.

@ast

Immunogenicity and safety of h ...... ix countries: a meta-analysis.

@en

P1476

Immunogenicity and safety of h ...... ix countries: a meta-analysis.

@en

P2093

Jan C Wilschut

http://www.w3.org/2001/XMLSchema#string

Jos Luttjeboer

http://www.w3.org/2001/XMLSchema#string

Maarten J Postma

http://www.w3.org/2001/XMLSchema#string

P2860

Performance of rotavirus vaccines in developed and developing countries

Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Measuring inconsistency in meta-analyses

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Positive outcomes influence the rate and time to publication, but not the impact factor of publications of clinical trial results

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

P304

265-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1093/JJCO/HYW192

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Koen Pouwels

Didik Setiawan

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28042137

http://www.w3.org/2001/XMLSchema#string

Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis.

about

P2860

P2860

Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698